Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Journey Medical (DERM) Receivables - Net (2020 - 2026)

Journey Medical filings provide 6 years of Receivables - Net readings, the most recent being $29.8 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 191.11% to $29.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $29.8 million, a 191.11% increase, with the full-year FY2025 number at $29.8 million, up 191.11% from a year prior.
  • Receivables - Net hit $29.8 million in Q4 2025 for Journey Medical, up from $18.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $31.7 million in Q3 2021 to a low of $8.0 million in Q3 2023.
  • Median Receivables - Net over the past 5 years was $18.0 million (2025), compared with a mean of $20.1 million.
  • Biggest five-year swings in Receivables - Net: plummeted 72.0% in 2023 and later skyrocketed 191.11% in 2025.
  • Journey Medical's Receivables - Net stood at $23.1 million in 2021, then increased by 22.05% to $28.2 million in 2022, then plummeted by 46.04% to $15.2 million in 2023, then plummeted by 32.79% to $10.2 million in 2024, then skyrocketed by 191.11% to $29.8 million in 2025.
  • The last three reported values for Receivables - Net were $29.8 million (Q4 2025), $18.0 million (Q3 2025), and $15.6 million (Q2 2025) per Business Quant data.